Stay updated on Nivolumab for Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.
Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics to the page. These additions provide navigation context without altering the trial details.SummaryDifference0.2%
- Check8 days agoChange DetectedAdded a consolidated Locations section listing Rio Grande do Sul and São Paulo as study sites in Brazil. The prior separate location headers were replaced to fit the unified Locations section.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved the Prostate Cancer topic and the MedlinePlus Genetics related topic from the related topics section. These resources are ancillary to the study and not required to interpret the trial details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check30 days agoChange DetectedAdded 'Prostate cancer' as a topic and introduced a related topics section with a link to 'MedlinePlus Genetics'.SummaryDifference0.2%
- Check37 days agoChange DetectedThe change is a minor revision update from v3.2.0 to v3.3.2; no alterations to the study details, eligibility criteria, interventions, or outcomes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check44 days agoChange DetectedThe government funding/operating status notice banner was removed from the page, and the study details remain unchanged.SummaryDifference0.4%
Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.